NCT00549042View on ClinicalTrials.gov

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

459

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Chronic Low Back Pain
Interventions
DRUG

OROS hydromorphone

hydromorphone 12, 16, 24, 32, 40, 48, or 64 mg tablets

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY